黄芪丹参粉针合光量子疗法治疗急性脑梗塞45例

Observation on Therapeutic Efficacy of Astragalus and salvia Powder Injection with Photons on 45 Patients with Acutely Cerebral Infarction

观察黄芪丹参粉针合光量子疗法治疗急性脑梗塞的临床疗效。对照组 ４０例，给予常规治疗及静点脉通液；治疗组 ４５例，给予常规治疗并静卢、黄芪注射液、丹参粉针和光量子疗法。两组患者于治疗前后测定血液流变学指标并进行疗效判断。治疗组和对照组治疗后，临床总有效率分别为９５ ６％、７２５％。经统计学处理。有显著差异性（Ｘ２＝８６ Ｐ＜０．０１）。血液流变学各项指标治疗组较对照组有显著性差异，两组均无不良反应。黄芪丹参合光量子治疗急性脑梗塞效果显著，用药安全。

Objective: To observe the therapeutic efficacy of therapy of astragalus and salvia powder injection with photons on acutely cerebral infarction. Methods: Eighty - five cases of acutely cerebral infarction were divided randomly into 2 groups. The control group(40 cases)was treated with conventional therapy and Low Molecular Dextran for intravenous drip. The treatment group(45 cases)was treated with conventional therapy and the therapy method of astragalus and salvia powder injection for intravenous drip. Detecting the parameters of blood rheology to evaluate the therapeutic efficacy before and after treatment of the two groups. Results:The total effective rates were 95. 6 % and 72. 5 % in treatment group and control one respectively. They are obviously difference b.etween the 2 groups (X2 = 8.6' P < 0. 01 ). The parameters of blood rheology show obviously difference between the treatment group and control one, and no side effects in 2 groups. Conclusions: There are better therapeutic efficacy and safeness of therapy of astragalus and salvia powder injection with photons on acutely cerebral infarction.